-
FUSN Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Fusion Pharmaceuticals (FUSN)
Company Profile
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 29.11 mm | 29.11 mm | 29.11 mm | 29.11 mm | 29.11 mm | 29.11 mm |
Cash burn (monthly) | 11.22 mm | 2.15 mm | 11.95 mm | 9.19 mm | 9.10 mm | 6.97 mm |
Cash used (since last report) | 126.63 mm | 24.24 mm | 134.88 mm | 103.66 mm | 102.71 mm | 78.68 mm |
Cash remaining | -97.52 mm | 4.87 mm | -105.77 mm | -74.55 mm | -73.60 mm | -49.57 mm |
Runway (months of cash) | -8.7 | 2.3 | -8.8 | -8.1 | -8.1 | -7.1 |
13F holders | Current |
---|---|
Total holders | 4 |
Opened positions | 0 |
Closed positions | 117 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 149.30 mm |
Total shares | 15.49 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Flynn James E | 6.40 mm | $35.21 mm |
HealthCap VII | 3.81 mm | $40.51 mm |
VAR Varian Medical Systems | 3.26 mm | $38.27 mm |
Seroba Life Sciences Management | 2.02 mm | $35.32 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Jun 24 | Bergstrom Donald A | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.64 | 17,000 | 78.88 k | 0 |
4 Jun 24 | Bergstrom Donald A | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.6 | 17,000 | 61.20 k | 0 |
4 Jun 24 | Bergstrom Donald A | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.15 | 17,000 | 138.55 k | 0 |
4 Jun 24 | Bergstrom Donald A | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 10.59 | 34,000 | 360.06 k | 0 |
4 Jun 24 | Philina Lee | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.64 | 17,000 | 78.88 k | 0 |
4 Jun 24 | Philina Lee | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.6 | 17,000 | 61.20 k | 0 |
4 Jun 24 | Philina Lee | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.15 | 17,000 | 138.55 k | 0 |
4 Jun 24 | Philina Lee | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 11.75 | 30,000 | 352.50 k | 0 |
4 Jun 24 | Eric Burak | Common Stock | Sale back to company | Dispose D | No | No | 0 | 38,490 | 0.00 | 0 |
4 Jun 24 | Eric Burak | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 63,700 | 0.00 | 0 |